000 | 01820 a2200505 4500 | ||
---|---|---|---|
005 | 20250515124247.0 | ||
264 | 0 | _c20080912 | |
008 | 200809s 0 0 eng d | ||
022 | _a1097-6809 | ||
024 | 7 |
_a10.1016/j.jvs.2008.04.011 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAkuzawa, Satoshi | |
245 | 0 | 0 |
_aInterleukin-1 receptor antagonist attenuates the severity of spinal cord ischemic injury in rabbits. _h[electronic resource] |
260 |
_bJournal of vascular surgery _cSep 2008 |
||
300 |
_a694-700 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIn Situ Nick-End Labeling |
650 | 0 | 4 | _aInjections, Spinal |
650 | 0 | 4 |
_aInterleukin 1 Receptor Antagonist Protein _xadministration & dosage |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMotor Activity _xdrug effects |
650 | 0 | 4 | _aNecrosis |
650 | 0 | 4 |
_aNerve Growth Factors _xcerebrospinal fluid |
650 | 0 | 4 |
_aNeurons _xdrug effects |
650 | 0 | 4 |
_aNeuroprotective Agents _xadministration & dosage |
650 | 0 | 4 |
_aNitric Oxide _xcerebrospinal fluid |
650 | 0 | 4 | _aRabbits |
650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
650 | 0 | 4 | _aS100 Calcium Binding Protein beta Subunit |
650 | 0 | 4 |
_aS100 Proteins _xcerebrospinal fluid |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 |
_aSpinal Cord Ischemia _xcerebrospinal fluid |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aKazui, Teruhisa | |
700 | 1 | _aShi, Enyi | |
700 | 1 | _aYamashita, Katsushi | |
700 | 1 | _aBashar, Abul Hasan Muhammad | |
700 | 1 | _aTerada, Hitoshi | |
773 | 0 |
_tJournal of vascular surgery _gvol. 48 _gno. 3 _gp. 694-700 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jvs.2008.04.011 _zAvailable from publisher's website |
999 |
_c18056479 _d18056479 |